Amy Gustafson

3.9k total citations
20 papers, 1.0k citations indexed

About

Amy Gustafson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Amy Gustafson has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Sensory Systems. Recurrent topics in Amy Gustafson's work include Ion Channels and Receptors (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Phytochemicals and Antioxidant Activities (3 papers). Amy Gustafson is often cited by papers focused on Ion Channels and Receptors (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Phytochemicals and Antioxidant Activities (3 papers). Amy Gustafson collaborates with scholars based in United States, France and China. Amy Gustafson's co-authors include Indira M. Raman, Daniel Emerling, Jeff DeFalco, Michael Kelly, Matthew A. J. Duncton, Yichin Liu, Fabien Vincent, Michelle Dourado, Margaret Nguyen and Benjamin D. Sellers and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Amy Gustafson

20 papers receiving 1.0k citations

Peers

Amy Gustafson
Tino Dyhring Denmark
Adrian J. Mogg United Kingdom
Stefano Patassini New Zealand
Izzy Boyfield United Kingdom
Suya Sun China
Amy Gustafson
Citations per year, relative to Amy Gustafson Amy Gustafson (= 1×) peers Patrizia Giannoni

Countries citing papers authored by Amy Gustafson

Since Specialization
Citations

This map shows the geographic impact of Amy Gustafson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Gustafson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Gustafson more than expected).

Fields of papers citing papers by Amy Gustafson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Gustafson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Gustafson. The network helps show where Amy Gustafson may publish in the future.

Co-authorship network of co-authors of Amy Gustafson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Gustafson. A scholar is included among the top collaborators of Amy Gustafson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Gustafson. Amy Gustafson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilewski, Christian, Sharada S. Labadie, BinQing Wei, et al.. (2023). Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors. ACS Medicinal Chemistry Letters. 15(1). 21–28. 4 indexed citations
2.
Li, Ke Sherry, John G. Quinn, Matthew J. Saabye, et al.. (2022). High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRASG12C by Intact Protein MS and Targeted MRM. Analytical Chemistry. 94(2). 1230–1239. 25 indexed citations
3.
Gustafson, Amy, et al.. (2021). Evaluation of an Outpatient Pharmacist Consult Service at a Large Academic Medical Center. SHILAP Revista de lepidopterología. 12(2). 13–13. 1 indexed citations
4.
Wang, Jing, Ryan Takahashi, Kevin DeMent, et al.. (2018). Development of a mass spectrometry-based tryptophan 2, 3-dioxygenase assay using liver cytosol from multiple species. Analytical Biochemistry. 556. 85–90. 3 indexed citations
5.
Yen, Ivana, Fergus Shanahan, Mark Merchant, et al.. (2018). Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors. Cancer Cell. 34(4). 611–625.e7. 47 indexed citations
6.
Pei, Zhonghua, Rohan Mendonca, Lewis Gazzard, et al.. (2018). Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2). ACS Medicinal Chemistry Letters. 9(5). 417–421. 34 indexed citations
7.
Wang, Tzu-Ming, Brandon M. Brown, Lunbin Deng, et al.. (2017). A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain. Neuropharmacology. 121. 204–218. 32 indexed citations
8.
Patel, Snahel, William J. Meilandt, Jinhua Chen, et al.. (2017). Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease. Journal of Medicinal Chemistry. 60(19). 8083–8102. 48 indexed citations
9.
Hackos, David H., Patrick J. Lupardus, Teddy Grand, et al.. (2016). Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Neuron. 89(5). 983–999. 139 indexed citations
10.
Labadie, Sharada S., Peter S. Dragovich, Richard Cummings, et al.. (2016). Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(18). 4492–4496. 17 indexed citations
11.
Nguyen, Margaret, Donogh J. R. O’Mahony, Qingling Zhang, et al.. (2015). Identification of orally-bioavailable antagonists of the TRPV4 ion-channel. Bioorganic & Medicinal Chemistry Letters. 25(18). 4011–4015. 29 indexed citations
12.
Jones, Steven W., Kevin Clark, Amy Gustafson, et al.. (2015). Compound Transfer by Acoustic Droplet Ejection Promotes Quality and Efficiency in Ultra-High-Throughput Screening Campaigns. SLAS TECHNOLOGY. 21(1). 64–75. 22 indexed citations
13.
Patel, Snahel, Seth F. Harris, Paul Gibbons, et al.. (2015). Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N -(1 H -Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12). Journal of Medicinal Chemistry. 58(20). 8182–8199. 45 indexed citations
14.
Maloney, Janice, Travis W. Bainbridge, Amy Gustafson, et al.. (2014). Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein. Journal of Biological Chemistry. 289(45). 30990–31000. 142 indexed citations
15.
Liu, Yichin, Maureen H. Beresini, Adam R. Johnson, et al.. (2011). Case Studies of Minimizing Nonspecific Inhibitors in HTS Campaigns That Use Assay-Ready Plates. SLAS DISCOVERY. 17(2). 225–236. 7 indexed citations
16.
DeFalco, Jeff, et al.. (2009). Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor. Bioorganic & Medicinal Chemistry Letters. 20(1). 276–279. 50 indexed citations
17.
Vincent, Fabien, Margaret Nguyen, Michelle Dourado, et al.. (2009). Identification and characterization of novel TRPV4 modulators. Biochemical and Biophysical Research Communications. 389(3). 490–494. 188 indexed citations
18.
Gustafson, Amy. (2004). Exercise and Depression. UND Scholarly Commons (University of North Dakota). 2 indexed citations
19.
Raman, Indira M., et al.. (2000). Ionic Currents and Spontaneous Firing in Neurons Isolated from the Cerebellar Nuclei. Journal of Neuroscience. 20(24). 9004–9016. 184 indexed citations
20.
Gustafson, Amy, et al.. (1994). Erythrocyte Lipid Extraction in Alcohol--Chloroform Systems: A Comparative Study.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 48(9). 753–758. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026